LATAM Bif Registry: January 2022 Report

Learn about the Latin American Registry of the Percutaneous Intervention of Coronary Bifurcations January 2022 report. The registry has already enrolled over 700 patients, which makes us most proud. 

More than 23 centers from Argentina, Mexico, Peru, Colombia, Ecuador, Bolivia, and Guatemala have joined the registry.

For those who still haven’t heard of it, LATAM Bif is a prospective multicenter registry created to assess the reality of coronary bifurcations percutaneous treatment, in order to identify the needs and set the best strategies to advance this technique in the daily practice. 

Learn more here

¿Cómo participar en el Registro LATAM Bif?

Escriba a latambif@gmail.com. Allí le enviarán toda la información y documentación necesaria para incorporarse al Registro LATAMBif coordinado por SOLACI Research.

¿Por qué participar en el Registro LATAM Bif?

  1. Posibilidad de contar con una base de datos propia dedicada a bifurcaciones coronarias, con variables unificadas para todos los centros de latinoamérica.
  2. Cada centro será el dueño de su data y podrá analizar sus resultados en tiempo real.
  3. Posibilidad de interactuar con centros de la región interesados en investigar y generar publicaciones.
  4. Posibilidad de difundir en eventos locales e internacionales los resultados del Registro LATAM Bif.
  5. En caso de necesitar asesoría para desarrollar proyectos de investigación y/o análisis estadísticos, contará con la asistencia del departamento SOLACI Research.
  6. El departamento SOLACI Research le brindará auditoría semanal y continua para que todos los datos, tanto iniciales como en el seguimiento anual (obligatorios) estén cargados correctamente.

Escriba ahora a latambif@gmail.com y comience a participar del registro LATAM Bif.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Fellow’s Corner – Case 2: Acute Myocardial Infarction Due to Simultaneous Occlusion of Two Coronary Arteries

Share your experience. Learn from experts. Grow as an interventional cardiologist. A new edition of the Fellow’s Corner is here, an academic exchange space designed...

Institutional Statement: SOLACI Expresses Its Solidarity with the People of Venezuela

The Latin American Society of Interventional Cardiology (SOLACI) expresses its deepest sorrow over the consequences of the earthquake that has affected Venezuela. We stand in...

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Guatemala Sessions 2026 – Young Interventional Cardiologists Contest – Submit Your Case

The call for applications to participate in the Young Interventional Cardiologists Competition at the Guatemala 2026 Regional Sessions is now open. The event will...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Coronary artery disease progression after transcatheter aortic valve replacement: quantitative coronary angiography and Quantitative Flow Ratio analysis

The coexistence of coronary artery disease and severe aortic stenosis is common among patients undergoing transcatheter aortic valve replacement (TAVR). However, the impact of...

UNICORN Technique to Prevent Coronary Obstruction During TAVI: Initial Results From a Multicenter Study

Coronary obstruction is an uncommon but potentially catastrophic complication of transcatheter aortic valve implantation (TAVI), particularly in valve-in-valve procedures, TAV-in-TAV interventions, or in patients...

Supera vs. Eluvia at 3 Years in Severely Calcified Femoropopliteal Lesions

Severe calcification remains one of the main predictors of restenosis and the need for repeat revascularization following endovascular treatment of femoropopliteal disease. In this...